C S Rinder
Overview
Explore the profile of C S Rinder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
327
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haddadin A, Ayoub C, Sevarino F, Rinder C
J Clin Monit Comput
. 2003 Feb;
15(2):125-9.
PMID: 12578086
Rapid detection of hemostatic defects presents a challenge for the anesthesiologist who must balance anesthetic and surgical considerations for maintaining adequate platelet and coagulant factors, while keeping allogenic blood exposure...
2.
Griffin M, Rinder H, Smith B, Tracey J, Kriz N, Li C, et al.
Anesth Analg
. 2001 Jun;
93(1):20-7.
PMID: 11429331
Unlabelled: Platelet dysfunction contributes to blood loss after cardiopulmonary bypass. This study examined the antiplatelet effects of heparin, protamine, and varying heparin/protamine ratios in an in vitro physiologic model and...
3.
Mathew J, Rinder C, Howe J, Fontes M, Crouch J, Newman M, et al.
Ann Thorac Surg
. 2001 Mar;
71(2):663-6.
PMID: 11235724
Background: Neurocognitive decline, often produced by atherosclerotic plaque embolization, remains a frequent complication of cardiopulmonary bypass. Plaque fragments may initiate local thrombosis, which, in turn, aggravates the embolic insult. Prothrombotic...
4.
Rinder C, Rinder H, Smith M, Tracey J, Fitch J, Li L, et al.
J Thorac Cardiovasc Surg
. 1999 Sep;
118(3):460-6.
PMID: 10469960
Objective: Complement activation is induced by cardiopulmonary bypass, and previous work found that late complement components (C5a, C5b-9) contribute to neutrophil and platelet activation during bypass. In the present study,...
5.
Rinder C, Rinder H, Johnson K, Smith M, Lee D, Tracey J, et al.
Circulation
. 1999 Aug;
100(5):553-8.
PMID: 10430771
Background: We previously demonstrated that inhibiting formation of terminal complement components (C5a and C5b-9) prevents platelet and neutrophil (PMN) but not monocyte activation during simulated extracorporeal circulation (SECC). This study...
6.
Rinder H, Tracey J, Recht M, DeCastro L, Rinder C, McHugh C, et al.
Thromb Haemost
. 1998 Oct;
80(3):457-62.
PMID: 9759627
The risk of serious bleeding in patients with immune thrombocytopenic purpura (ITP) appears to be less than in comparably thrombocytopenic patients with megakaryocytic hypoplasia. It has been proposed that this...
7.
Rinder H, Schuster J, Rinder C, Wang C, Schweidler H, Smith B
Blood
. 1998 Mar;
91(4):1288-94.
PMID: 9454759
There are no readily applicable methods to routinely assess thrombosis risk and treatment response in thrombocytosis. Reticulated platelets (RP) define the most recently released platelets in the circulation, and the...
8.
Rinder C, Mathew J, Rinder H, Tracey J, Davis E, Smith B
J Lab Clin Med
. 1997 Jun;
129(6):592-602.
PMID: 9178725
Complications of cardiopulmonary bypass (CPB) may be associated with either immune suppression or immune activation, but the specific effects of CPB on many lymphocyte and monocyte subsets are unclear. In...
9.
10.
Harris S, Rinder C, Rinder H, Tracey J, Smith B, Hines R
Anesthesiology
. 1995 Dec;
83(6):1145-52.
PMID: 8533905
Background: The time course and reversibility of sodium nitroprusside's in vivo inhibition of platelet function are unclear. Methods: Platelet aggregation and P-selectin expression as measures of platelet dense and alpha-granule...